KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Outstanding
Ratios

CRISPR Therapeutics AG (CRSP) Long-Term Debt Issuances (2016)

Historic Long-Term Debt Issuances for CRISPR Therapeutics AG (CRSP) over the last 1 years, with Q4 2016 value amounting to $10000.0.

  • CRISPR Therapeutics AG's Long-Term Debt Issuances changed N/A to $10000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $35.0 million, marking a year-over-year change of. This contributed to the annual value of $35.0 million for FY2016, which is 844.43% down from last year.
  • As of Q4 2016, CRISPR Therapeutics AG's Long-Term Debt Issuances stood at $10000.0.
  • CRISPR Therapeutics AG's 5-year Long-Term Debt Issuances high stood at $35.0 million for Q1 2016, and its period low was $10000.0 during Q4 2016.